Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Licensed Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 4 contracts
Sources: License Agreement, License Agreement (Homology Medicines, Inc.), License Agreement (Homology Medicines, Inc.)
Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 3 contracts
Sources: License Agreement (Avedro Inc), License Agreement (Avedro Inc), License Agreement (Avedro Inc)
Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 3 contracts
Sources: License Agreement (Gevo, Inc.), License Agreement (Arrowhead Research Corp), License Agreement (Helicos Biosciences Corp)
Marking. Licensee agrees to ▇m▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 3 contracts
Sources: License Agreement (Gevo, Inc.), License Agreement (VIASPACE Inc.), License Agreement (VIASPACE Inc.)
Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Licensed Patent Rights, unless such marking is commercially infeasible Rights in accordance with normal commercial practices of pharmaceutical or biotechnology companies in the Field, in which case the Parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 2 contracts
Sources: License Agreement (Immune Design Corp.), License Agreement (Immune Design Corp.)
Marking. Licensee agrees to ▇▇▇▇ mark the Licensed Products with the numbers of applicable issued patents pate▇▇▇ within the Exclusively Licensed Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 1 contract
Marking. Licensee agrees to ▇m▇▇▇ or cause to be marked the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights and Improvement Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 1 contract
Sources: License Agreement (Ecotality, Inc.)
Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights or Improvement Patent Rights, unless such marking is not legally required or commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 1 contract
Sources: License Agreement (RxSight, Inc.)
Marking. Licensee agrees to ▇▇▇▇ or cause to be marked the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights and Improvement Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties parties shall cooperate to devise a Alchemy Enterprises, LTD. -10- _________________ commercially reasonable alternative to such marking.
Appears in 1 contract
Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights or Improvement Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Fieldpractices, in which case the Parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 1 contract
Marking. Licensee agrees to ▇▇▇▇ the Licensed Products with the numbers of applicable issued patents within the Exclusively Licensed Patent Rights or Improvement Patent Rights, unless such marking is commercially infeasible in accordance with normal commercial practices in the Field, in which case the Parties shall cooperate to devise a commercially reasonable alternative to such marking.
Appears in 1 contract
Sources: License Agreement (IsoPlexis Corp)